Meera Mohan

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 55

Top Topics

Acute Lymphoblastic Leukemia

Multiple Myeloma

Systematic Review

Top Venues

Blood cancer journal

Bone marrow transplantation

American journal of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Saurabh Chhabra, James H Jerkins, Kathleen Monahan, Aniko Szabo, Nirav N Shah, Sameem Abedin, Lyndsey Runaas, Timothy S Fenske, Marcelo C Pasquini, Bronwen E Shaw, Williams R Drobyski, Wael Saber, Anita D Souza, Binod Dhakal, Meera Mohan, Walter Longo, Mehdi Hamadani
Severity and organ distribution of chronic graft-versus-host disease with posttransplant cyclophosphamide-based versus methotrexate/calcineurin inhibitor-based allogeneic hematopoietic cell transplantation. Bone marrow transplantation 59 (3) (2024)
Zimu Gong, Godsfavour Umoru, Jorge Monge, Nishi Shah, Ghulam Rehman Mohyuddin, Sabarinath Venniyil Radhakrishnan, Rajshekhar Chakraborty, Leo Rasche, Carolina D Schinke, Anita D Souza, Meera Mohan
Adverse effects and non-relapse mortality of BCMA directed T cell therapies in multiple myeloma: an FAERS database study. Blood cancer journal 14 (1) (2024)
Zimu Gong, Godsfavour Umoru, Jorge Monge, Nishi Shah, Ghulam Rehman Mohyuddin, Sabarinath Venniyil Radhakrishnan, Rajshekhar Chakraborty, Leo Rasche, Carolina D Schinke, Anita D Souza, Meera Mohan
Adverse effects and non-relapse mortality of BCMA directed T cell therapies in multiple myeloma: an FAERS database study. Blood cancer journal 14 (1) (2024)
Karun Neupane, Gliceida Galarza Fortuna, Riyasha Dahal, Timothy Martin Schmidt, Rafael Fonseca, Rajshekhar Chakraborty, Kelly Ann Koehn, Meera Mohan, Hira S Mian, Luciano José Megale Costa, Douglas W Sborov, Ghulam Rehman Mohyuddin
Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review. Blood cancer journal 14 (1) (2024)
Meera Mohan, Jorge Monge, Nishi Shah, Danny Luan, Mark Forsberg, Vineel Bhatlapenumarthi, Metodi Balev, Anannya Patwari, Heloise Cheruvalath, Divaya Bhutani, Sharmilan Thanendrarajan, Binod Dhakal, Maurizio Zangari, Samer Al Hadidi, Dennis Cooper, Suzanne Lentzsch, Frits Van Rhee, Anita D'Souza, Aniko Szabo, Carolina D Schinke, Rajshekhar Chakraborty
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study. Blood cancer journal 14 (1) (2024)
Meera Mohan, Aniko Szabo, Anannya Patwari, Jean Esselmann, Tanvi Patel, Ramya Bachu, Lisa E Rein, Abhishek Janardan, Vineel Bhatlapenumarthi, Evanka Annyapu, Catherine Skoog, Areyl Goff, Samer Al Hadidi, Sabarinath Venniyil Radhakrishnan, Sharmilan Thanendrarajan, Maurizio Zangari, Nirav N Shah, Frits Van Rhee, Binod Dhakal, Mehdi Hamadani, Anita D Souza, Carolina D Schinke
Autologous stem cell boost improves persistent immune effector cell associated hematotoxicity following BCMA directed chimeric antigen receptor T (CAR T) cell therapy in multiple myeloma. Bone marrow transplantation 59 (5) (2024)
Zimu Gong, Godsfavour Umoru, Jorge Monge, Nishi Shah, Ghulam Rehman Mohyuddin, Sabarinath Venniyil Radhakrishnan, Rajshekhar Chakraborty, Leo Rasche, Carolina D Schinke, Anita D Souza, Meera Mohan
Adverse effects and non-relapse mortality of BCMA directed T cell therapies in multiple myeloma: an FAERS database study. Blood cancer journal 14 (1) (2024)
Saurabh Chhabra, James H Jerkins, Kathleen Monahan, Aniko Szabo, Nirav N Shah, Sameem Abedin, Lyndsey Runaas, Timothy S Fenske, Marcelo C Pasquini, Bronwen E Shaw, Williams R Drobyski, Wael Saber, Anita D Souza, Binod Dhakal, Meera Mohan, Walter Longo, Mehdi Hamadani
Severity and organ distribution of chronic graft-versus-host disease with posttransplant cyclophosphamide-based versus methotrexate/calcineurin inhibitor-based allogeneic hematopoietic cell transplantation. Bone marrow transplantation 59 (3) (2024)
Meera Mohan, Aniko Szabo, Anannya Patwari, Jean Esselmann, Tanvi Patel, Ramya Bachu, Lisa E Rein, Abhishek Janardan, Vineel Bhatlapenumarthi, Evanka Annyapu, Catherine Skoog, Areyl Goff, Samer Al Hadidi, Sabarinath Venniyil Radhakrishnan, Sharmilan Thanendrarajan, Maurizio Zangari, Nirav N Shah, Frits Van Rhee, Binod Dhakal, Mehdi Hamadani, Anita D Souza, Carolina D Schinke
Autologous stem cell boost improves persistent immune effector cell associated hematotoxicity following BCMA directed chimeric antigen receptor T (CAR T) cell therapy in multiple myeloma. Bone marrow transplantation (2024)
Meera Mohan, Aniko Szabo, Anannya Patwari, Jean Esselmann, Tanvi Patel, Ramya Bachu, Lisa E Rein, Abhishek Janardan, Vineel Bhatlapenumarthi, Evanka Annyapu, Catherine Skoog, Areyl Goff, Samer Al Hadidi, Sabarinath Venniyil Radhakrishnan, Sharmilan Thanendrarajan, Maurizio Zangari, Nirav N Shah, Frits Van Rhee, Binod Dhakal, Mehdi Hamadani, Anita D Souza, Carolina D Schinke
Autologous stem cell boost improves persistent immune effector cell associated hematotoxicity following BCMA directed chimeric antigen receptor T (CAR T) cell therapy in multiple myeloma. Bone marrow transplantation 59 (5) (2024)
Meera Mohan, Jorge Monge, Nishi Shah, Danny Luan, Mark Forsberg, Vineel Bhatlapenumarthi, Metodi Balev, Anannya Patwari, Heloise Cheruvalath, Divaya Bhutani, Sharmilan Thanendrarajan, Binod Dhakal, Maurizio Zangari, Samer Al Hadidi, Dennis Cooper, Suzanne Lentzsch, Frits Van Rhee, Anita D'Souza, Aniko Szabo, Carolina D Schinke, Rajshekhar Chakraborty
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study. Blood cancer journal 14 (1) (2024)
Meera Mohan, Jorge Monge, Nishi Shah, Danny Luan, Mark Forsberg, Vineel Bhatlapenumarthi, Metodi Balev, Anannya Patwari, Heloise Cheruvalath, Divaya Bhutani, Sharmilan Thanendrarajan, Binod Dhakal, Maurizio Zangari, Samer Al Hadidi, Dennis Cooper, Suzanne Lentzsch, Frits Van Rhee, Anita D'Souza, Aniko Szabo, Carolina D Schinke, Rajshekhar Chakraborty
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study. Blood cancer journal 14 (1) (2024)
Meera Mohan, Carolina Schinke
Risk stratification in multiple myeloma: Are we there yet? British journal of haematology (2024)
Othman Salim Akhtar, Aniko Szabo, Vineel Bhatlapenumarthi, Mark Forsberg, Metodi Balev, Anannya Patwari, Heloise Cheruvalath, Divaya Bhutani, Sharmilan Thanendrarajan, Binod Dhakal, Maurizio Zangari, Tanvi Patel, Asis Shrestha, Samer Al Hadidi, Dennis Cooper, Suzanne Lentzsch, Frits van Rhee, Mansi R Shah, Aishee Bag, Anita D Souza, Carolina Schinke, Rajshekhar Chakraborty, Nishi Shah, Meera Mohan
Immune prognostic score predicts the risk of infection and survival outcomes in patients with relapsed multiple myeloma treated with bispecific antibodies. British journal of haematology (2024)
Karun Neupane, Gliceida Galarza Fortuna, Riyasha Dahal, Timothy Martin Schmidt, Rafael Fonseca, Rajshekhar Chakraborty, Kelly Ann Koehn, Meera Mohan, Hira S Mian, Luciano José Megale Costa, Douglas W Sborov, Ghulam Rehman Mohyuddin
Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review. Blood cancer journal 14 (1) (2024)
Meera Mohan, Jorge Monge, Nishi Shah, Danny Luan, Mark Forsberg, Vineel Bhatlapenumarthi, Metodi Balev, Anannya Patwari, Heloise Cheruvalath, Divaya Bhutani, Sharmilan Thanendrarajan, Binod Dhakal, Maurizio Zangari, Samer Al Hadidi, Dennis Cooper, Suzanne Lentzsch, Frits Van Rhee, Anita D'Souza, Aniko Szabo, Carolina D Schinke, Rajshekhar Chakraborty
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study. Blood cancer journal 14 (1) (2024)
Meera Mohan, Aniko Szabo, Anannya Patwari, Jean Esselmann, Tanvi Patel, Ramya Bachu, Lisa E Rein, Abhishek Janardan, Vineel Bhatlapenumarthi, Evanka Annyapu, Catherine Skoog, Areyl Goff, Samer Al Hadidi, Sabarinath Venniyil Radhakrishnan, Sharmilan Thanendrarajan, Maurizio Zangari, Nirav N Shah, Frits Van Rhee, Binod Dhakal, Mehdi Hamadani, Anita D Souza, Carolina D Schinke
Autologous stem cell boost improves persistent immune effector cell associated hematotoxicity following BCMA directed chimeric antigen receptor T (CAR T) cell therapy in multiple myeloma. Bone marrow transplantation 59 (5) (2024)
Zimu Gong, Godsfavour Umoru, Jorge Monge, Nishi Shah, Ghulam Rehman Mohyuddin, Sabarinath Venniyil Radhakrishnan, Rajshekhar Chakraborty, Leo Rasche, Carolina D Schinke, Anita D Souza, Meera Mohan
Adverse effects and non-relapse mortality of BCMA directed T cell therapies in multiple myeloma: an FAERS database study. Blood cancer journal 14 (1) (2024)
Saurabh Chhabra, James H Jerkins, Kathleen Monahan, Aniko Szabo, Nirav N Shah, Sameem Abedin, Lyndsey Runaas, Timothy S Fenske, Marcelo C Pasquini, Bronwen E Shaw, Williams R Drobyski, Wael Saber, Anita D Souza, Binod Dhakal, Meera Mohan, Walter Longo, Mehdi Hamadani
Severity and organ distribution of chronic graft-versus-host disease with posttransplant cyclophosphamide-based versus methotrexate/calcineurin inhibitor-based allogeneic hematopoietic cell transplantation. Bone marrow transplantation (2024)
Karun Neupane, Gliceida Galarza Fortuna, Riyasha Dahal, Timothy Martin Schmidt, Rafael Fonseca, Rajshekhar Chakraborty, Kelly Ann Koehn, Meera Mohan, Hira S Mian, Luciano José Megale Costa, Douglas W Sborov, Ghulam Rehman Mohyuddin
Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review. Blood cancer journal 14 (1) (2024)
Karun Neupane, Gliceida Galarza Fortuna, Riyasha Dahal, Timothy Martin Schmidt, Rafael Fonseca, Rajshekhar Chakraborty, Kelly Ann Koehn, Meera Mohan, Hira S Mian, Luciano José Megale Costa, Douglas W Sborov, Ghulam Rehman Mohyuddin
Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review. Blood cancer journal 14 (1) (2024)
Fateeha Furqan, Vineel Bhatlapenumarthi, Binod Dhakal, Timothy S Fenske, Faiqa Farrukh, Walter Longo, Othman Akhtar, Anita D'Souza, Marcelo C Pasquini, Guru Subramanian Guru Murthy, Lyndsey Runaas, Sameem Abedin, Meera Mohan, Nirav N Shah, Mehdi Hamadani
Outpatient administration of CAR T-cell therapies using a strategy of no remote monitoring and early CRS intervention. Blood advances 8 (16) (2024)
Fateeha Furqan, Vineel Bhatlapenumarthi, Binod Dhakal, Timothy S Fenske, Faiqa Farrukh, Walter Longo, Othman Akhtar, Anita D'Souza, Marcelo C Pasquini, Guru Subramanian Guru Murthy, Lyndsey Runaas, Sameem Abedin, Meera Mohan, Nirav N Shah, Mehdi Hamadani
Outpatient administration of CAR T-cell therapies using a strategy of no remote monitoring and early CRS intervention. Blood advances 8 (16) (2024)
Fateeha Furqan, Vineel Bhatlapenumarthi, Binod Dhakal, Timothy S Fenske, Faiqa Farrukh, Walter Longo, Othman Salim Akhtar, Anita D'Souza, Marcelo C Pasquini, Guru Subramanian Guru Murthy, Lyndsey Runaas, Sameem Abedin, Meera Mohan, Nirav N Shah, Mehdi Hamadani
Outpatient Administration of CAR T-cell Therapies Using a Strategy of No Remote Monitoring and Early CRS Intervention. Blood advances (2024)
Karun Neupane, Gliceida Galarza Fortuna, Riyasha Dahal, Timothy Martin Schmidt, Rafael Fonseca, Rajshekhar Chakraborty, Kelly Ann Koehn, Meera Mohan, Hira S Mian, Luciano José Megale Costa, Douglas W Sborov, Ghulam Rehman Mohyuddin
Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review. Blood cancer journal 14 (1) (2024)
Karun Neupane, Gliceida Galarza Fortuna, Riyasha Dahal, Timothy Martin Schmidt, Rafael Fonseca, Rajshekhar Chakraborty, Kelly Ann Koehn, Meera Mohan, Hira S Mian, Luciano José Megale Costa, Douglas W Sborov, Ghulam Rehman Mohyuddin
Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review. Blood cancer journal 14 (1) (2024)
Meera Mohan, Carolina Schinke
Risk stratification in multiple myeloma: Are we there yet? British journal of haematology 204 (5) (2024)
Meera Mohan, Anai Kothari, Nathaniel Verhagen, Aditya Shreenivas, Sabarinath Venniyil Radhakrishnan, Binod Dhakal, Carlos E Figueroa Castro, Saurabh Chhabra, Siegfried Janz, Marcello Pasquini, Mehdi Hamadani, Aniko Szabo, Anita D Souza, null null
Blood and marrow transplant within 4 weeks of SARS-CoV-2 infection is associated with increased risk of mortality: a National COVID Cohort Collaborative (N3C) Study. Bone marrow transplantation (2023)
Meera Mohan, Siegfried Janz, Ruta Brazauskas, Michael B Dwinell, Bi Qing Teng, Grant Yun, Jing Dong, Marcelo C Pasquini, Sergio A Giralt, Heather J Landau, Edward Stadtmauer, Amrita Krishnan, Anita D Souza
Increased CXCL10 is seen at 1-year after autologous hematopoietic cell transplantation in multiple myeloma patients on maintenance lenalidomide therapy. Bone marrow transplantation (2023)
Meera Mohan, Rajshekhar Chakraborty, Susan Bal, Anoma Nellore, Muhamed Baljevic, Anita D Souza, Peter G Pappas, Jesus G Berdeja, Natalie Callander, Luciano José Megale Costa
Recommendations on prevention of infections during chimeric antigen receptor T-cell and bispecific antibody therapy in multiple myeloma. British journal of haematology (2023)
Lindsay Hammons, Shabi Haider, Andrew Jay Portuguese, Rahul Banerjee, Aniko Szabo, Marcelo C Pasquini, Saurabh Chhabra, Sabarinath Radhakrishnan, Meera Mohan, Ravi Narra, Jing Dong, Siegfried Janz, Nirav N Shah, Mehdi Hamadani, Anita D Souza, Parameswaran Hari, Binod Dhakal
Chimeric antigen receptor and bispecific T-cell engager therapies in multiple myeloma patients with prior allogeneic transplantation. British journal of haematology (2023)
Meera Mohan, Siegfried Janz, Ruta Brazauskas, Michael B Dwinell, Bi Qing Teng, Grant Yun, Jing Dong, Marcelo C Pasquini, Sergio A Giralt, Heather J Landau, Edward Stadtmauer, Amrita Krishnan, Anita D Souza
Increased CXCL10 is seen at 1-year after autologous hematopoietic cell transplantation in multiple myeloma patients on maintenance lenalidomide therapy. Bone marrow transplantation (2023)
Al-Ola Abdallah, Zahra Mahmoudjafari, Nausheen Ahmed, Wei Cui, Leyla Shune, Joseph McGuirk, Meera Mohan, Ghulam Rehman Mohyuddin, Aimaz Afrough, Omar Alkharabsheh, Shebli Atrash
Clinical efficacy of retreatment of daratumumab-based therapy (D2) in daratumumab-refractory multiple myeloma. European journal of haematology (2023)
Rajshekhar Chakraborty, Divaya Bhutani, Mathew S Maurer, Meera Mohan, Suzanne Lentzsch, Anita D Souza
Safety and efficacy of teclistamab in systemic immunoglobulin light chain amyloidosis. Blood cancer journal 13 (1) (2023)
Ariel Kleman, Arun K Singavi, Lauren Pommert, Angela Joy Mathison, Parameswaran N Hari, Binod Dhakal, Meera Mohan, Siegfried Janz, Jennifer Mary Knight, Mithun Vinod Shah, Carolina D Schinke, Robert Thomas Burns, George Francis Steinhardt, Sridhar Rao, Karen-Sue Barker Carlson
A timeline of genetic variant enrichment: from multiple myeloma diagnosis to myeloma-associated myeloid malignancy. Blood advances (2023)
Al-Ola Abdallah, Zahra Mahmoudjafari, Nausheen Ahmed, Wei Cui, Leyla Shune, Joseph McGuirk, Meera Mohan, Ghulam Rehman Mohyuddin, Aimaz Afrough, Omar Alkharabsheh, Shebli Atrash
Clinical efficacy of retreatment of daratumumab-based therapy (D2) in daratumumab-refractory multiple myeloma. European journal of haematology (2023)
Meera Mohan, Zimu Gong, Timothy Cody Ashby, Samer Al Hadidi, Sharmilan Thanendrarajan, Carolina Schinke, Daisy Alapat, John D Shaughnessy, Fenghuang Zhan, Frits van Rhee, Jeffery R Sawyer, Erming Tian, Maurizio Zangari
Concomitant deletion of the short arm (Del 1p13.3) and amplification or gain (1q21) of chromosome 1 by fluorescence in situ hybridization are associated with a poor clinical outcome in multiple myeloma. Cancer (2023)
Samer Al Hadidi, Aniko Szabo, Jean Esselmann, Lindsay Hammons, Munawwar Hussain, Yetunde Ogunsesan, Nishanth Thalambedu, Fatima Khan, Jaskirat Sethi, Abhishek Janardan, Sabarinath Venniyil Radhakrishnan, Sharmilan Thanendrarajan, Carolina D Schinke, Binod Dhakal, Siegfried Janz, Saurabh Chhabra, Anita D Souza, Maurizio Zangari, Frits Van Rhee, Meera Mohan
Clinical outcome of patients with relapsed refractory multiple myeloma listed for BCMA directed commercial CAR-T therapy. Bone marrow transplantation (2022)
Meera Mohan, Melody Renee Becnel, Urvi A Shah, Huaying Dong, Sravani Gundarlapalli, Timothy Peterson, Jennifer S Orozco, Sandra Horowitz, Saurabh Chhabra, Binod Dhakal, Sharmilan Thanendrarajan, Sabarinath Venniyil Radhakrishnan, Samer Al Hadidi, Carlyn Rose Tan, Sham Mailankody, Malin Hultcrantz, Neha Korde, Hani Hassoun, Alexander M Lesokhin, Sheeba K Thomas, Krina K Patel, Elisabet E Manasanch, Donna M Weber, Aniko Szabo, Gregory P Kaufman, Hans C Lee, Maurizio Zangari, Frits Van Rhee, Saad Z Usmani, Anita D Souza, Robert Z Orlowski, Carolina D Schinke
Clinical efficacy of sequencing CD38 targeting monoclonal antibodies in relapsed refractory multiple myeloma: A multi-institutional experience. American journal of hematology 97 (7) (2022)
Aala Dweik, Hadeel Dweik, Hira Mian, Meera Mohan, Carolina Schinke, Samer Al Hadidi
Gender disparities in multiple myeloma publications. EJHaem 3 (3) (2022)
Meera Mohan, Sravani Gundarlapalli, Aniko Szabo, Naveen Yarlagadda, Sunilkumar Kakadia, Manojna Konda, Anusha Jillella, Amisha Fnu, Yetunde Ogunsesan, Lakshmi Yarlagadda, Nishant Thalambedu, Hussain Munawar, Monica Graziutti, Samer Al Hadidi, Daisy Alapat, Sharmilan Thanendrarajan, Maurizio Zangari, Frits Van Rhee, Carolina D Schinke
Tandem autologous stem cell transplantation in patients with persistent bone marrow minimal residual disease after first transplantation in multiple myeloma. American journal of hematology 97 (6) (2022)
Meera Mohan, Lisa E Rein, Nishanth Thalambedu, Yetunde Ogunsesan, Munawwar Hussain, Jaskirat Sethi, Fatima Khan, Sravani Gundarlapalli, Lakshmi Yarlagadda, Binod Dhakal, Mary Price, Megan Shirey, Davie Warner, Sharmilan Thanendrarajan, Siegfried Janz, Sabarinath Venniyil Radhakrishnan, Samer Al Hadidi, Aniko Szabo, Anita D Souza, Maurizio Zangari, Frits Van Rhee, Saurabh Chhabra, Carolina D Schinke
Corneal toxicity with belantamab mafodotin: Multi-institutional real-life experience. American journal of hematology 97 (12) (2022)
Jing Dong, Zhuping Garacci, Christopher Staffi Buradagunta, Anita D Souza, Meera Mohan, Ashley Cunningham, Siegfried Janz, Binod Dhakal, Aaron P Thrift, Parameswaran N Hari
Black patients with multiple myeloma have better survival than white patients when treated equally: a matched cohort study. Blood cancer journal 12 (2) (2022)
Meera Mohan, Sneha Nagavally, Binod Dhakal, Sabarinath Venniyil Radhakrishnan, Saurabh Chhabra, Anita D'Souza, Parameswaran N Hari
Risk of infections with B-cell maturation antigen-directed immunotherapy in multiple myeloma. Blood advances 6 (8) (2022)
Al-Ola Abdallah, Zahra Mahmoudjafari, Tahani Atieh, Nausheen Ahmed, Wei Cui, Leyla Shune, Meera Mohan, Joseph McGuirk, Cassie Remker, Margaret Foss, Ellie Karloff, Heather Fitch, Shebli Atrash
Neutralizing antibody responses against SARS-CoV-2 in patients with plasma cell disorders who are on active treatment after two doses of mRNA vaccination. European journal of haematology 109 (5) (2022)
Meera Mohan, Samantha Kendrick, Aniko Szabo, Naveen K Yarlagadda, Dinesh Atwal, Yadav Pandey, Arya Mariam Roy, Richa Parikh, James Lopez, Sharmilan Thanendrarajan, Carolina D Schinke, Daisy Alapat, Jeffrey R Sawyer, Erming Tian, Guido Tricot, Frits van Rhee, Maurizio Zangari
Clinical implications of loss of bone marrow minimal residual disease negativity in multiple myeloma. Blood advances (2021)
Meera Mohan, Naveen Yarlagadda, Aniko Szabo, Amrit Singh, Sergio Piña-Oviedo, Carolina D Schinke
Clinical characteristics of testicular extramedullary involvement in multiple myeloma. American journal of hematology 96 (3) (2021)
Al-Ola Abdallah, Ghulam Rehman Mohyuddin, Nausheen Ahmed, Meera Mohan, Wei Cui, Leyla Shune, Zahra Mahmoudjafari, Joseph McGuirk, Siddhartha Ganguly, Shebli Atrash
Outcomes of VDPACE with an immunomodulatory agent as a salvage therapy in relapsed/refractory multiple myeloma with extramedullary disease. EJHaem 2 (4) (2021)
Meera Mohan, James C Meek, Mary Elizabeth Meek, Ralph Broadwater, Daisy Alapat, Frits van Rhee
Combinatorial treatment for unresectable unicentric Castleman disease. European journal of haematology 107 (4) (2021)
Bicky Thapa, Gulrayz Ahmed, Meera Mohan, Volodymyr Shponka, Parameswaran N Hari
Pulmonary Lymphangitic Spread of Multiple Myeloma as Early Relapse after Autologous Stem Cell Transplantation. Case reports in hematology 2021 (2021)
Meera Mohan, Aniko Szabo, Naveen Yarlagadda, Sravani Gundarlapalli, Sharmilan Thanendrarajan, Samantha Kendrick, Carolina D Schinke, Daisy Alapat, Jeffrey Sawyer, Erming Tian, Guido Tricot, Frits Van Rhee, Maurizio Zangari
Persistent bone marrow minimal residual disease as a "high-risk" disease feature in multiple myeloma. American journal of hematology 96 (9) (2021)
Dante Pennipede, Ghulam Rehman Mohyuddin, Ryan Hawkins, Siddhartha Ganguly, Leyla Shune, Nausheen Ahmed, Meera Mohan, Wei Cui, Zahra Mahmoudjafari, Joseph McGuirk, Shebli Atrash, Al-Ola Abdallah
Carfilzomib, cyclophosphamide, and dexamethasone (KCd) for the treatment of triple-class relapsed/refractory multiple myeloma (RRMM). European journal of haematology 107 (6) (2021)
Meera Mohan, Parameswaran Hari, Binod Dhakal
Immunotherapy in Multiple Myeloma-Time for a Second Major Paradigm Shift. JCO oncology practice 17 (7) (2021)
James Lopez, Mihir Raval, Meera Mohan
Intractable hypercalcemia in a patient with multiple myeloma: An infectious etiology. Transplant infectious disease : an official journal of the Transplantation Society 22 (5) (2020)
Meera Mohan, Sandra Susanibar-Adaniya, Amy Buros, Juan Carlos Rico Crescencio, Mary J Burgess, Katherine Lusardi, Faith Davies, Gareth Morgan, Frits Vanrhee, Maurizio Zangari, Carolina Schinke, Sharmilan Thanendrarajan, Atul Kothari
Bacteremias following autologous stem cell transplantation for multiple myeloma: Risk factors and outcomes. Transplant infectious disease : an official journal of the Transplantation Society 21 (2) (2019)